Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 December, 2018 13:45 IST
Granules India gets nod for Methylergonovine 0.2 mg tablets
Source: IRIS | 17 May, 2018, 09.43AM
Comments  |  Post Comment

Granules India, today announced that the US FDA has approved its Abbreviated New Drug Applications (ANDA) for Methylergonovine 0.2 mg Tablets. The AN DA was filed by Granules Pharmaceuticals Inc., a wholly owned subsidiary of Granules India Limited. The approved ANDA is the bioequivalent to the reference listed drug product (RLD), Methergine 0.2 MG.

Methylergonovine is a semi-synthetic ergot alkaloid used for the prevention and control of postpartum haemorrhage.

''Granules Pharmaceuticals Inc., our R&D and manufacturing subsidiary in Virginia was established with an objective to foray into the development and manufacture of products that are niche, on several levels. Our first product approval from this site is a ''first generic,'' to the market and is a testimony to our objectives and execution ca pabilities," said Krishna Prasad Chigurupati, Chairman and Managing Director, Granules India.

(Q,N,C,F)*

Shares of the company gained Rs 5.05, or 5.22%, to trade at Rs 101.80. The total volume of shares traded was 140,536 at the BSE (9.31 a.m., Thursday).



Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Commercial Engineers & Body Builders Company wins order worth Rs 1.52 bn - 19-Dec-2018 10:51
Glenmark Pharmaceuticals forays into branded dermatology segment in U.S. - 19-Dec-2018 10:33
Power Mech Projects wins orders worth Rs 2.45 bn - 18-Dec-2018 10:42
M&M to hike stake in associate company Sampo Rosenlew - 18-Dec-2018 10:37
Glenmark Pharma gets nod for Fluocinolone Acetonide oil - 18-Dec-2018 10:08
BGR Energy Systems bags order worth Rs 494 mn from Tamilnadu Transmission Corp - 18-Dec-2018 10:04
Lupin receives approval from USFDA for Clobazam tablets - 18-Dec-2018 10:01
Ahluwalia Contracts (India) secures new order worth RS 4.25 bn - 17-Dec-2018 15:31
Lupin receives tentative USFDA approval for Tadalafil tablets - 17-Dec-2018 14:49
Gayatri Projects bags new order worth Rs 4.93 bn - 17-Dec-2018 09:43
Zydus Cadila receives USFDA approvals for two drugs - 17-Dec-2018 09:39
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer